The global healthcare and laboratory labels market is anticipated to grow at a 4.5% CAGR from 2023 to 2033, from US$ 9.59 billion in 2023 to US$ 14.89 billion in 2033. The market is expected to grow at a 4.1% annual pace by 2023.
The demand for pharmaceutical products is expected to rise in the near future, and new products will also likely enter the market. The pressure-sensitive labels and labelling tapes industry is anticipated to increase much more quickly than all other businesses in response to rising labelling demand.
For More Insights on this Market, Get A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12535
Factors including a high prevalence of diseases, an increase in hospital admissions, and an increase in product launches are expected to fuel market revenue growth throughout the course of the projected year. Labels are essential in the healthcare and pharmaceutical industries. Medical laboratory labelling and lab equipment are used to enhance patient safety in many clinical care, administrative, and operational domains.
Many medical laboratory labels are available to improve efficiency, improve patient safety and security, reduce errors, secure and manage medical data, and organise patient paperwork and records. The labels used in medical laboratories are used to keep track of tools and other assets, such as medical gear.
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst @ https://www.futuremarketinsights.com/customization-available/rep-gb-12535
Demand Study for Healthcare and Laboratory Labels (2017 to 2022) Compared to Market Prospects (2023 to 2033)
As its name suggests, the UDI (Unique Device Identification) is a method used to identify and mark medical equipment across the healthcare supply chain. A system for uniquely identifying devices was mandated by the US FDA in order to properly identify devices during distribution and usage. Each UDI shall be made available in plain text and in an automated identification and data capture (AIDC) format.
A device that is intended for more than one use must be directly tagged with the UDI and reprocessed before each use. Device medical laboratory labels and packages must display dates in a uniform manner that adheres to accepted international standards.
Additionally, by advocating for harmonized legislation for Unique Device Identification (UDI), based on international standards, The IMDRF (International Medical Device Regulator Forum) and the European Commission are focusing on a globally consistent and unified approach that is to improve patient safety.
Get 20% Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-12535
Key Takeaways
- The Polyolefin segment in the material category is to advance at a CAGR of 5% from 2023 to 2033, worth US$ 4.02 billion by 2023.
- The laboratory segment in the end user category is to develop at a CAGR of 5.4% between 2023 and 2033, worth US$ 2.46 billion by 2023.
- The paper segment in the material category of the healthcare and laboratory labels industry is to acquire a market share of 64.9% by 2023.
- The Pharmaceutical segment, in the end, user category is to grab a market share of 30.1% by 2023.
- The United States to capture a CAGR of 3.7% between 2023 and 2033, worth US$ 3,862.9 million in 2023.
- German healthcare and laboratory labels industry to advance at a CAGR of 3.6% from 2023 to 2033, reaching US$ 686.4 million in 2023.
- India is to expand at a CAGR of 7.4% during the forecast period, worth US$ 2354.7 million by 2023.
- China healthcare and laboratory labels market is to expand at a CAGR of 6% from 2023 to 2033, reaching US$ 2332 million in 2023.
- The United States to obtain 89.4% of the market share by 2023.
- Germany healthcare and laboratory labels industry to hold a market share of 21.7% by 2023.
- France to secure a market share of 16.8% by 2023.
- India is to witness 79.6% of the market share by 2023.
- China healthcare and laboratory labels industry to grab a market share of 56.1% by 2023.
Economic Analysis
The healthcare and laboratory label manufacturers that operate in this market are very focused on mergers and acquisitions to accelerate healthcare and laboratory labels market expansion in the upcoming year. Healthcare and laboratory label manufacturers are concentrating on the rollout of novel goods to create and acquire a global footprint.
Key Players:
- Avery Dennison Corporation
- CCL Industries Inc.
- 3M Company
- Multi-Color Corporation
- UPM Raflatac Corporation
- Brady Corporation
- Sato Holdings Corporation
Key Segments Covered in healthcare and Laboratory Labels Industry Research
Market By End-user :
- Pharmaceuticals
- Nutraceuticals
- Medical Devices
- Blood Banks
- Hospital Services
- Laboratories
By Region :
- North America Healthcare and Laboratory Labels Market
- Latin America Healthcare and Laboratory Labels Market
- Europe Healthcare and Laboratory Labels Market
- East Asia Healthcare and Laboratory Labels Market
- South Asia Healthcare and Laboratory Labels Market
- Oceania Healthcare and Laboratory Labels Market
- Middle East & Africa (MEA) Healthcare and Laboratory Labels Market
About Us:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years
Contact Us:
Future Market Insights Inc.
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse all Reports: https://www.futuremarketinsights.com/reports
